Amsterdam, Netherlands

Fiona Clare Kimberley

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fiona Clare Kimberley: Innovator in Antibody Research

Introduction

Fiona Clare Kimberley is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a focus on inflammatory diseases and cancer, her work is paving the way for innovative treatments.

Latest Patents

Fiona holds 2 patents related to her groundbreaking research. Her latest patents include "Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof." This invention pertains to a binding compound that specifically targets human APRIL. The compositions of anti-APRIL specific antibodies and their methods of use are designed to modulate the biological activity of APRIL, particularly in the context of inflammatory diseases, inhibition of cell proliferation, and cancer.

Career Highlights

Fiona is currently associated with Bionovion Holding B.V., where she continues to advance her research in antibody development. Her innovative approach and dedication to her work have established her as a key figure in her field.

Collaborations

Fiona collaborates with notable colleagues, including Jan Paul Medema and Hans Van Eenennaam, who contribute to her research endeavors and enhance the impact of her work.

Conclusion

Fiona Clare Kimberley is a trailblazer in the field of antibody research, with her patents reflecting her commitment to addressing critical health challenges. Her contributions are vital to the ongoing development of effective therapies for inflammatory diseases and cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…